Similar Management Seen for Dialysis-Requiring AKI, ESKD Patients
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 5, 2023 -- Patients with dialysis-requiring acute kidney injury (AKI-D) are prescribed the same dialysis as end-stage kidney disease (ESKD) patients, but some AKI-D patients have the potential to recover, according to a research letter published online Sept. 28 in the Journal of the American Society of Nephrology.
Ian E. McCoy, M.D., from the University of California San Francisco, and colleagues examined AKI-D patient management for adults who initiated outpatient hemodialysis. Initial dialysis prescriptions and the frequency of blood work and timed urine collection in the first 30 days were compared for incident AKI-D and incident ESKD patients. AKI-D patients were followed for three months or until recovery or death.
A total of 1,754 patients who initiated outpatient hemodialysis for AKI-D and 6,197 who initiated dialysis for ESKD were included in the study. The researchers found that 94 percent of AKI-D patients were initially prescribed dialysis three times/week, which was similar to ESKD patients (95 percent). Other components of dialysis were also similar, including duration, dialysate temperate, and sodium. Timed urine collections were completed in 28 percent of AKI-D patients during the first 30 days of outpatient dialysis compared with 16 percent in the ESKD group. Overall, 41 percent of AKI-D patients recovered during follow-up. For 70 percent of AKI-D patients, there were no changes to prescribed dialysis frequency or session duration. Dialysis frequency was weaned in 18 percent, and session duration was weaned in 9 percent of those who recovered; 72 percent discontinued dialysis with no change from the initial prescription.
"For those who have the potential to recover, remaining on dialysis may place them at unnecessary risk for heart disease, infection, organ damage, and death," McCoy said in a statement.
Several authors disclosed ties to industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
Kidneys From Deceased Donors Who Were on Dialysis Are Suboptimal
FRIDAY, May 24, 2024 -- Receipt of a kidney from a deceased donor who underwent dialysis is associated with an increased incidence of delayed graft function, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.